The Types segmentation classifies Medical Consortia by organizational structure and governance model, encompassing Academic Consortia, Industry‑Led Consortia, and Hybrid Consortia. Academic Consortia are typically formed by universities and research institutes, emphasizing open science and grant‑funded projects; they generate modest but steady revenue, contributing approximately 30% of the market due to lower commercial pricing. Industry‑Led Consortia are driven by pharmaceutical, biotech, or medical device firms that seek proprietary data and accelerated product pipelines, commanding the largest share at about 55% because of higher subscription fees and service contracts. Hybrid Consortia combine academic rigor with industry funding, balancing innovation with commercial applicability, and represent the remaining 15% of market volume. Understanding these type distinctions clarifies how governance, funding mechanisms, and stakeholder objectives influence the overall market size and growth trajectory, a key element of any market taxonomy analysis.